Insider · CIK 0002066370
Robert E. Bancroft
Files at AEON (AEON Biopharma, Inc.). First filing -, latest -.
In brief
Robert E. Bancroft files SEC Form 4 as CEO, president and director at AEON (AEON Biopharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert E. Bancroft has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | AEON AEON Biopharma, Inc. | AGrant or award Class A Common Stock | +3,000,000 | $0.00 | $0 | 3,177,103 | Feb 19, 2026 |
| May 14, 2025 | AEON AEON Biopharma, Inc. | AGrant or award Class A Common Stock | +177,103 | $0.00 | $0 | 177,103 | May 16, 2025 |
| Apr 29, 2025 | AEON AEON Biopharma, Inc. | AGrant or award Stock Optionderivative | +59,034 | $0.00 | $0 | 59,034 | May 1, 2025 |
Questions about Robert E. Bancroft
Answered from the filings on this page, as of the latest one.
Is Robert E. Bancroft buying or selling?
Robert E. Bancroft has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert E. Bancroft's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert E. Bancroft has 0.
Where does Robert E. Bancroft file Form 4?
Robert E. Bancroft has filed Form 4 at AEON (AEON Biopharma, Inc.) as PRESIDENT & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.